 |
||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||
 |
Unique Qualities of the DuraHeart LVAS
The DuraHeart® LVAS is the first device to reach clinical trial that combines centrifugal pump and magnetic-levitation technologies. The unique design of the DuraHeart LVAS incorporates the following characteristics:
- Flow rate from two to eight liters per minute with motor speeds between twelve hundred and twenty-four hundred RPM
- Secondary hydrodynamic suspension
- Flow rate that varies with physiological changes
Additional features:
- Silent pump operation
- An advanced Vascutek GelWeave™ outflow graft
- Multiple inflow options for optimal fit
- Thin flexible percutaneous cable
Not available in the U.S.